AaronMorrisEtraMD

PubMed

• Amphiregulin, ST2,and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD.
  Aaron M Etra, Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie C Gergoudis, George Morales, Nikolaos Spyrou, Steven Kowalyk, Paibel Aguayo-Hiraldo, Yu Akah...> ;Blood Advances. 2024 Apr 19
• The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD.
  Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert W Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Fra...> ;Blood Advances. 2024 Apr 19
• 1 citations
  A Day 14 Endpoint for Acute GVHD Clinical Trials.
  Al Malki, M. M., Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M Al Malki, Francis Ayuk, Peter Bader, Ja...> ;Transplantation and Cellular Therapy. 2024 Apr 1
• A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
  Kapoor, U., Muna Qayed, Urvi Kapoor, Scott Gillespie, Adrianna Westbrook, Paibel Aguayo-Hiraldo, Francis A Ayuk, Mina Aziz, Janna Baez, Hannah Choe, Zachariah DeFilipp...> ;Transplantation and Cellular Therapy. 2024 Mar 27
• Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee.
  Zainab Shahid, Aaron M Etra, John E Levine, Marcie L Riches, Aliyah Baluch, Joshua A Hill, Ryo Nakamura, Amir A Toor, Celalettin Ustun, Jo-Anne H Young, Miguel-Angel P...> ;Transplantation and Cellular Therapy. 2024 Mar 6
• Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis.
  Al Malki, M. M., Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting Dr. med, Paibel Aguayo-Hiraldo, Francis Ayuketang Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matt...> ;Blood Advances. 2024 Feb 7
• 2 citations
  Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.
  Yu Akahoshi, Nikolaos Spyrou, William J Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber, Hannah K Choe, Elizabeth O Hexner, Wolf Rösler, Aaron M Etra, Karamjeet...> ;Blood Advances. 2023 Aug 22
• 2 citations
  The utility of biomarkers in acute GVHD prognostication.
  Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra, William J Hogan, Wolf Rösler, Elizabeth Hexner, Zachariah DeFilipp, Ran Reshef, Chan...> ;Blood Advances. 2023 Sep 12
• 9 citations
  Effective treatment of low-risk acute GVHD with itacitinib monotherapy.
  Kapoor, U., Aaron Etra, Alexandra Capellini, Amin Alousi, Monzr M Al Malki, Hannah Choe, Zachariah DeFilipp, William J Hogan, Carrie L Kitko, Francis Ayuk, Janna Baez,...> ;Blood. 2023 Feb 2
• 5 citations
  SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia.
  Nicholas C J Lee, Bhavisha Patel, Aaron Etra, Taha Bat, Ibrahim F Ibrahim, Madhuri Vusirikala, Mingyi Chen, Flavia Rosado, Jesse Manuel Jaso, Neal S Young, Weina Chen> ;Blood Advances. 2022 Jul 12
• 8 citations
  Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
  Kapoor, U., Aaron Etra, Stephanie Gergoudis, George Morales, Nikolaos Spyrou, Jay Shah, Steven Kowalyk, Francis Ayuk, Janna Baez, Chantiya Chanswangphuwana, Yi-Bin Che...> ;Blood Advances. 2022 Jun 28
• 11 citations
  Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
  Makda Getachew Zewde, George Morales, Isha Gandhi, Umut Ozbek, Paibel Aguayo-Hiraldo, Francis Ayuk, Janna Baez, Chantiya Chanswangphuwana, Hannah Choe, Zachariah DeFil...> ;Transplantation and Cellular Therapy. 2021 Aug 30
• 8 citations
  Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease
  Stelios Kasikis, Aaron Etra, John E. Levine> ;Biodrugs. 2021 Jan 1
• 21 citations
  Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.
  Stephanie Gergoudis, Zachariah DeFilipp, Umut Ozbek, Karamjeet S. Sandhu, Aaron Etra, Hannah K. Choe, Carrie L. Kitko, Francis Ayuk, Mina Aziz, Janna Baez, Kaitlyn Ben...> ;Blood Advances. 2020 Dec 22
• 16 citations
  Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant.
  Kapoor, U., Kapoor, U., Kapoor, U., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2020 Feb 4
• 57 citations
  The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
  Kapoor, U., Kapoor, U., Kapoor, U., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Blood Advances. 2019 Dec 10
• 15 citations
  Evaluating the safety of emicizumab in patients with hemophilia A.
  Arielle L Langer, Aaron Etra, Louis M. Aledort> ;Expert Opinion on Drug Safety. 2018 Nov 28
• 123 citations
  MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
  Hannah Major-Monfried, Anne S. Renteria, Attaphol Pawarode, Pavan Reddy, Francis Ayuk, Ernst Holler, Yvonne A. Efebera, William J. Hogan, Matthias Wölfl, Muna Qayed, E...> ;Blood. 2018 Jun 21
• 5 citations
  Death of woman with peripartum influenza B virus infection and necrotizing pneumonia.
  Joshua L. Rein, Aaron Etra, Jatinbhai J. Patel, Janet L. Stein, Aimee L. Rivers, Hayley B. Gershengorn, Elizabeth Awerbuch, Barry N. Kreiswirth, Sanjana C. Koshy> ;Emerging Infectious Diseases. 2014 Jul 1
• Join now to see all

Abstracts/Posters

• The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
  Aaron Etra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019